Free Trial

VectivBio (VECT) Competitors

VectivBio logo
$16.85
0.00 (0.00%)
(As of 11/1/2024 ET)

VECT vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

VectivBio vs.

180 Life Sciences (NASDAQ:ATNFW) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, community ranking, analyst recommendations, media sentiment, dividends and institutional ownership.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
VectivBio Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
VectivBio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
VectivBio N/A N/A N/A

VectivBio received 10 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
VectivBioOutperform Votes
10
43.48%
Underperform Votes
13
56.52%

180 Life Sciences has higher earnings, but lower revenue than VectivBio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
VectivBio$27.34MN/A-$93.74MN/AN/A

Summary

VectivBio beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VECT vs. The Competition

MetricVectivBioBiological Products IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.15B$5.33B$8.52B
Dividend YieldN/A1.77%5.07%4.13%
P/E RatioN/A16.44128.4016.13
Price / SalesN/A321.081,491.7792.21
Price / CashN/A149.0539.5634.18
Price / Book2.694.024.765.07
Net Income-$93.74M-$42.25M$118.92M$225.46M
7 Day PerformanceN/A1.81%-0.39%0.07%
1 Month PerformanceN/A8.56%6.06%3.93%
1 Year PerformanceN/A35.10%38.23%32.51%

VectivBio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
N/A$16.85
flat
N/AN/A$0.00$27.34M0.0030High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-9.1%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
+28.6%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040
ALVOW
Alvotech
N/A$3.20
+5.3%
N/AN/A$0.00$306.77M0.004Positive News
ALVO
Alvotech
2.0875 of 5 stars
$13.02
+0.3%
$18.00
+38.2%
+51.6%$0.00$93.38M-4.911,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$12.54
flat
N/A+19.1%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.07
-64.6%
N/A+119.3%$0.00$35.24M0.0070Gap Down
High Trading Volume
BTMDW
biote
N/A$0.56
-5.1%
N/A-46.8%$0.00$187.23M0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:VECT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners